[Enteral feeding in extremely low birth weight infants with a gestational age of <28 weeks versus ≥ 28 weeks]

Ying Li1, Fan Wu1

  • 1Department of Neonatology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.

Insights

Extremely low birth weight infants born at ≥ 28 weeks gestational age experience less feeding intolerance and reach full enteral feeding sooner than those born earlier. However, they have a higher risk of extrauterine growth retardation, requiring tailored feeding strategies.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Perinatal Medicine

Background:

  • Extremely low birth weight (ELBW) infants often face challenges with enteral feeding and feeding intolerance (FI).
  • Gestational age (GA) at birth is a critical factor influencing neonatal outcomes.
  • Understanding feeding progression differences based on GA is crucial for optimizing care.

Purpose of the Study:

  • To compare enteral feeding progression and the incidence of feeding intolerance (FI) in ELBW infants based on gestational age (GA).
  • To analyze differences between infants with GA < 28 weeks and GA ≥ 28 weeks.

Main Methods:

  • Retrospective analysis of ELBW infants admitted between January 2018 and January 2020.
  • Infants categorized into two groups: GA < 28 weeks (n=41) and GA ≥ 28 weeks (n=38).
  • Comparison of enteral feeding parameters and FI rates during hospitalization.

Main Results:

  • Infants with GA ≥ 28 weeks had a significantly lower incidence of recurrent FI (32% vs 54%) and shorter duration of FI.
  • The GA < 28 weeks group required longer to achieve full enteral feeding.
  • While GA ≥ 28 weeks group had better weight gain velocity and shorter hospital stay, they showed a higher incidence of extrauterine growth retardation (EUGR).

Conclusions:

  • ELBW infants with GA ≥ 28 weeks achieve full enteral feeding earlier and have lower FI recurrence rates compared to those with GA < 28 weeks.
  • The higher EUGR rate in the GA ≥ 28 weeks group necessitates proactive and potentially more aggressive enteral feeding strategies.
  • Gestational age significantly impacts feeding tolerance and growth outcomes in ELBW infants.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
376
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
602
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
58
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
389
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
44